ArticleCancers2021

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Kimberly M Burcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.